<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

LSX USA White 500x 

   STRATEGY, INVESTMENT AND PARTNERING FOR LIFE SCIENCE EXECUTIVES   

 
2nd Annual Conference
7-8 October 2019
Convene Convention Center
Boston | USA
#LSXUSA

DOWNLOAD THE BROCHURE

Confirmed Partners

Arnold Porter
Freshfields Bruckhaus Deringer 300x200
Goldman Sachs
NDA Group
Wilson Sonsini

Peer-to-peer knowledge exchange, curated group meetings, and content to address the questions on the minds of CEOs

LSX World Congress USA

What is it and who is it for?

The LSX World Congress USA is a gathering of the industries foremost life science executive leaders.

Now in it’s second year, LSX USA follows the unique style and format of the LSX World Congress in London focusing on strategy, investment and partnering.

The three core pillars of our community are:

  • CxOs of life sciences companies
  • Heads of Pharma Business Development
  • VC and PE Investors

We address and look to find solutions to the respective challenges they face, and connect them with strategies, solutions and contacts to enable growth and development in their businesses.

LSX USA Venn 500x

Early Confirmed Speakers

Ted Tanner Jr., CTO and Chief Architect, Watson Health, IBM (1)

Ted Tanner Jr.
CTO & Chief Architect, Watson Health, IBM
IBM 300x

Melissa Fensterstock, Co-Founder and CEO, Landsdowne Labs

Melissa Fensterstock
Co-Founder & CEO, Landsdowne Labs
Landsdowne Labs

Carolyn Witte, Co-Founder and CEO, Tia

Carolyn Witte
Co-Founder & CEO, Tia
Tia 300x

Joel Wishkovsky, CEO, Simple Health

Joel Wishkovsky
CEO, Simple Contacts
Simple Contacts 300x

Todd Foley, Managing Partner, MPM Capital

Todd Foley
Managing Partner, MPM Capital
MPM Capital

Peter Dudek, Partner, MRL Ventures Fund

Peter Dudek
Partner, MRL Ventures Fund
MRL Ventures Fund

Priyanka Rohatgi, Managing Director, Head, Ipsen Ventures

Priyanka Rohatgi
Managing Director, Head, Ipsen Ventures
Ipsen Ventures

Adam Houghton, Vice President and Head, AbbVie Ventures

Adam Houghton
VP & Head, AbbVie Ventures
AbbVie Ventures

Jay Stamatis, Vice President, Head of Business Development and Acquisitions, Abbvie 300x

Jay Stamatis
VP, Head of Business Development & Acquisitions, Abbvie
AbbVie Ventures 300x

Nicole Kholodnov, VP of Clinical Operations, Parsley Health

Nicole Kholodnov
VP of Clinical Operations, Parsley Health
Parsley Health

Kelly Gold, VP, Corporate Development, CAMP4 Therapeutics

Kelly Gold
VP, Corporate Development, CAMP4 Therapeutics
CAMP4 Therapeutics

Dan Grau, CEO, Sojournix

Dan Grau
CEO, Sojournix
Sojournix

Marshall Smith, Head of Global Healthcare, Goldman Sachs

Marshall Smith
Head of Global Healthcare, Goldman Sachs
Goldman Sachs

Rogerio Vivaldi, CEO, Sigilon Therapeutics

Rogerio Vivaldi
CEO, Sigilon Therapeutics
Sigilon Therapeutics

Ricky Sun, Partner, Life Sciences, Bain Capital

Ricky Sun
Partner, Life Sciences, Bain Capital
Bain Capital

Adam Rosenberg, President & CEO, Rodin Therapeutics

Adam Rosenberg
President & CEO, Rodin Therapeutics
Rodin Therapeutics

Laurent Audoly, President & CEO, Kymera Therapeutics

Laurent Audoly
President & CEO, Kymera Therapeutics
Kymera Therapeutics

Meredith Fisher, Partner, Partners Innovation Fund, Partners Healthcare

Meredith Fisher
Partner, Partners Innovation Fund, Partners Healthcare

Partners Healthcare

Thomas Lönngren, Former Head of the EMA and Strategic Advisor, NDA Group

Thomas Lönngren
Former Head of the EMA & Strategic Advisor, NDA Group

NDA Group

Veronique Riethuisen, SVP, Global Head of Business Development & Alliance Management, Ipsen

Veronique Riethuisen
SVP, Global Head of Business Development & Alliance Management, Ipsen

Ipsen Ventures 300x

Nouhad Husseini, VP, Head of Business Development, Regeneron Pharmaceuticals

Nouhad Husseini
VP, Head of Business Development, Regeneron Pharmaceuticals

Regeneron Pharmaceuticals 300x

Agenda at a Glance

Forum - 7 October

09:00


1-2-1 Meetings

12:30


Lunch Break

13:30


Investor Forum


Early Stage CEO Forum


Growth Stage CEO Forum


Publicly Listed CEO Forum

17:30


Investor Drinks & Dinner


CEO Drinks & Dinner

Conference - 8th October

09:00


Keynote Plenary


1-2-1 Meetings

10:30


Conference


Pharma BD Forum


Licensing Strategies Workshop


Clinical Strategies Workshop


1-2-1 Meetings

12:30


Lunch Break

13:30


Conference


Pharma BD Forum


Exit Strategies Workshop


Market Access Strategies Workshop


1-2-1 Meetings

15:30


Plenary


1-2-1 Meetings

IPO Bootcamp - 9th October

09:00


The IPO Bootcamp is a full-day forum in which a team of some of the world’s foremost experts, advisers, bankers and consultants help 8 CEOs and CFOs navigate the how, what, where and when of a successful US IPO. The key USPs are a very high level and calibre of attendee and program, exclusivity, and a personalised approach.

LSX USA

Network

Network

Biotech, medtech and deeptech CxOs will be coming to Boston and joined by investors and pharma to address key issues facing their businesses and the wider healthcare sector.

Partner

Partner

1-2-1 partnering is a key focus across the two days. Pre-event all attendees and see who is attending, message each other and book meetings to find investors, investment opportunities and connect with potential partners.

Learn

Learn

Understand the latest trends, forecasts and insights from leading investors, life science executives, pharma BD&L heads and industry KOLs through presentations and more informal workshops and group discussions.